Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability and sensitivity towards body fluids. Oral route of administration is very convenient route; however, the bioavailability of proteins and peptides is less, when administered orally due to degradation of amino acids in gastrointestinal tract. With the advancement in technology formulation containing protein and peptides are introduced in the market that can be orally administered with no change in therapeutic activity and pharmacokinetic aspects.
The market for oral protein and peptides is expected to grow due to technological advancements, R&D activities and increase in prevalence of chronic disorders. High cost of R&D activities is the major challenge for oral proteins and peptides market.
Oral Proteins and Peptides Market analysis by Drugs
The market is segmented into Linaclotide, Ostora, IN-105(Insulin), Plecantide and others. Insulin is used mostly amongst the various oral proteins and peptides that are being developed.
Oral Proteins and Peptides Market analysis by Technology
The market is segmented into Gastrointestinal Permeation Enhancement Technology (GIPET), Eligen, Peptelligence, Oral antibody platform, Multi-Matrix Systems (MMX) and others. GIPET, Eligen and Peptelligence are some of the prominent technologies used in oral protein and peptides formulations development.
Oral Proteins and Peptides Market analysis by Geography
Geographically, the market is segmented into North America, Europe, Asia-Pacific and the LAMEA. North America is the most eminent market of oral proteins and peptides market.
Zydus cadilla Healthcare, Pfizer, Inc., Roche, Inc., Sanofi-Aventis LLC, Abbott Laboratories, Novartis AG are the major key players of this market. Many large and small companies are doing in-house research for developing new technologies. Several proteins and peptides are in preclinical and discovery stage.
High level analysis
According to Porter’s five forces model, the bargaining power of buyers is high due to limited number of sellers in the market and bargaining power of buyers is less, as there is no substitute available in the market. Threat of new entrant is less due to high capital investment require for start- up. SWOT analysis gives direction for strategic planning. Major Key players are focusing on Research and Development. Many products are of key players are under preclinical trials and clinical trials.
Oral proteins and peptide market is segmented on the basis of drugs available, technology used for development and geography.
MARKET BY DRUGS
MARKET BY TECHNOLOGY
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
DelveInsight Drug Report, “ViraferonPeg- Drug Insights, 2017” highlights the ViraferonPeg marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the ViraferonPeg covering the total sales estimation and also provides the ViraferonPeg sales performance during the historical period ...
February 2017 | $1000 | View Details >>
Summary Kobayashi Pharmaceutical Co., Ltd. (Kobayashi) is a manufacturer and distributor of pharmaceutical and health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, sanitary products, household sundries, and body warmers. It also offers health food products, dietary food products, and nutritional supplements and skin ...
May 2014 | $250 | View Details >>
Summary Aileron Therapeutics, Inc. (Aileron) is a biopharmaceutical company. The company develops and markets stapled peptides. Its products include ALRN-5281 and P53. Aileron’s ALRN-5281 is a growth-hormone-releasing hormone agonist for treating orphan endocrine disorders, such as adult growth hormone deficiency, HIV lipodystrophy and metabolic and endocrine diseases. The company’s P53 is ...
July 2014 | $250 | View Details >>
DelveInsight’s, “ Fever-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fever. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical ...
February 2017 | $1250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research